EyePoint Pharmaceuticals, Inc.
Nasdaq EYPT · Watertown, MA
Works in Infectious disease · Ophthalmology · Respiratory
EyePoint Pharmaceuticals, Inc. is a clinical trial sponsor based in Watertown, MA, listed as Nasdaq EYPT. It has 4 active clinical trials with 1,280 planned participants, in Infectious disease, Ophthalmology and Respiratory. Since 2021 it has completed 8 trials and stopped 5 early.
Trial track record · since 2021
Financials · Nasdaq EYPT
Fundraising
Pipeline · 4 active trials
| Stage | Trial | Status |
|---|---|---|
Questions about EyePoint Pharmaceuticals, Inc
EyePoint Pharmaceuticals, Inc is lead sponsor of 4 active clinical trials on ClinicalTrials.gov, with 1,280 planned participants, in Infectious disease, Ophthalmology, Respiratory. Since 2021 it has completed 8 trials and stopped 5 early.
EyePoint Pharmaceuticals, Inc is based in Watertown, MA and is listed as Nasdaq EYPT. The address is the one on its SEC filings, which name the establishment or the registrant, not always the group's head office.
From public sources only: ClinicalTrials.gov for trials, FDA's Data Dashboard, warning-letter listing and enforcement reports for the FDA record, and SEC filings for financials. Approve Suite is not affiliated with EyePoint Pharmaceuticals, Inc; every record links to the source, and nothing here is advice.
See the rest of this profile
A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.
Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-10-05.
Approve Suite is not affiliated with EyePoint Pharmaceuticals, Inc.. Informational only.
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.